Atlas Trials

Matinas BioPharma Nanotechnologies, Inc.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Matinas BioPharma Nanotechnologies, Inc.

RecordFirmDate
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3 (NCT05541107)Matinas BioPharma Nanotechnologies, Inc.2023-01-01
Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia (NCT04177680)Matinas BioPharma Nanotechnologies, Inc.2020-06-03
Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis (NCT03167957)Matinas BioPharma Nanotechnologies, Inc.2019-12-01
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) (NCT04031833)Matinas BioPharma Nanotechnologies, Inc.2019-10-24
Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia (NCT03187691)Matinas BioPharma Nanotechnologies, Inc.2019-08-01
Efficacy and Safety of Oral Encochleated Amphotericin B for the Treatment of Cryptococcal Infection (NCT03196921)Matinas BioPharma Nanotechnologies, Inc.2018-10-01

Track Matinas BioPharma Nanotechnologies, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.